Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Shulman DS"'
Autor:
Ilcisin L; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA.; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Han R; Children's Oncology Group, Monrovia, CA, USA., Krailo M; Children's Oncology Group, Arcadia, CA, USA.; Department of Population and Public Health Sciences Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Shulman DS; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Weil BR; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Weldon CB; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Umaretiya P; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA., Aziz-Bose R; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Greenzang KA; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Gorlick R; Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Reed DR; Division of Pediatric Solid Tumors, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Randall RL; Department of Orthopaedic Surgery, University of California Davis Health, Sacramento, CA, USA., Nadel H; Division of Radiology, Lucille Packard Children's Hospital at Stanford University, Stanford, CA, USA., Binitie O; Department of Surgery, Moffitt Cancer Center, Tampa, FL, USA., Dubois SG; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Janeway KA; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Bona K; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Oct 01; Vol. 116 (10), pp. 1664-1674.
Autor:
Gikandi A; Harvard Medical School, Boston, Massachusetts, USA., Chi SN; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., Yeo KK; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., O'Neill AF; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., Shulman DS; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., DuBois SG; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., Collins NB; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Apr; Vol. 13 (8), pp. e7154.
Autor:
Campbell K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Posner A; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Chen N; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Cavanaugh K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Bhushan K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Shulman DS; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., George S; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Klega K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Crompton B; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., London WB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Dec; Vol. 70 (12), pp. e30681. Date of Electronic Publication: 2023 Sep 16.
Autor:
Olsen HE; Boston Children's Hospital, Boston, Massachusetts, USA., Liu KX; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston Children's Hospital, Boston, Massachusetts, USA., Frazier AL; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., O'Neill AF; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., Shulman DS; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Nov; Vol. 70 (11), pp. e30652. Date of Electronic Publication: 2023 Aug 29.
Autor:
Yang DM; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX.; Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX., Zhou Q; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX., Furman-Cline L; Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, TX., Cheng X; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX., Luo D; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX., Lai H; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX.; Department of Biostatistics and Data Science, School of Public Health, University of Texas Health Science Center at Houston (UT Health), Houston, TX., Li Y; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX., Jin KW; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX., Yao B; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX., Leavey PJ; Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX.; Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, TX., Rakheja D; Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX., Lo T; Children's Oncology Group Statistics and Data Center, Monrovia, CA., Hall D; Children's Oncology Group Statistics and Data Center, Monrovia, CA., Barkauskas DA; Children's Oncology Group Statistics and Data Center, Monrovia, CA.; Department of Population and Public Health Sciences, Keck School of Medicine of the University of Southern California, Los Angeles, CA., Shulman DS; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Janeway K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Khanna C; Ethos Discovery, San Diego, CA., Gorlick R; Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX., Menzies C; Children's Medical Center, Dallas, TX., Zhan X; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX.; Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX., Xiao G; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX.; Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX.; Department of Bioinformatics, The University of Texas Southwestern Medical Center, Dallas, TX., Skapek SX; Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX.; Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, TX., Xu L; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX.; Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX., Klesse LJ; Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX.; Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, TX., Crompton BD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.; Broad Institute of Harvard and MIT, Cambridge, MA., Xie Y; Quantitative Biomedical Research Center, Peter O'Donnell Jr School of Public Health, The University of Texas Southwestern Medical Center, Dallas, TX.; Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX.; Department of Bioinformatics, The University of Texas Southwestern Medical Center, Dallas, TX.
Publikováno v:
JCO clinical cancer informatics [JCO Clin Cancer Inform] 2023 Sep; Vol. 7, pp. e2300104.
Autor:
Shulman DS; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Merriam P; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Choy E; Massachusetts General Hospital, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Guenther LM; St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Cavanaugh KL; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Kao PC; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Posner A; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Bhushan K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Fairchild G; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Barker E; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Klega K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Stegmaier K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., Crompton BD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., London WB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA., DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2023 Jul; Vol. 12 (14), pp. 15207-15216. Date of Electronic Publication: 2023 Jun 12.
Autor:
Neel DV; Harvard Medical School, Boston, Massachusetts, USA., Ma C; Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada., Collins NB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., Hornick JL; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Demetri GD; Harvard Medical School, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute and Ludwig Center at Harvard, Boston, Massachusetts, USA., Shulman DS; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2023 Jan; Vol. 12 (1), pp. 170-178. Date of Electronic Publication: 2022 Jun 07.
Autor:
Shulman DS; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Chen S; Nationwide Children's Hospital, Columbus, OH, USA., Hall D; Children's Oncology Group, Monrovia, CA, USA., Nag A; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA., Thorner AR; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA., Lessnick SL; Nationwide Children's Hospital, Columbus, OH, USA., Stegmaier K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Krailo MD; Children's Oncology Group, Monrovia, CA, USA.; Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Barkauskas DA; Children's Oncology Group, Monrovia, CA, USA.; Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Church AJ; Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Crompton BD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA. briand_crompton@dfci.harvard.edu.; Broad Institute, Cambridge, MA, USA. briand_crompton@dfci.harvard.edu.
Publikováno v:
British journal of cancer [Br J Cancer] 2022 Dec; Vol. 127 (12), pp. 2220-2226. Date of Electronic Publication: 2022 Oct 11.
Autor:
Shulman DS; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Whittle SB; Texas Children's Cancer and Hematology Centers, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA., Surdez D; Bone Sarcoma Research Laboratory, Balgrist University Hospital, University of Zurich, Zurich, Switzerland., Bailey KM; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., de Álava E; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC/Department of Normal and Pathological Cytology and Histology, School of Medicine, University of Seville, Seville, Spain., Yustein JT; Texas Children's Cancer and Hematology Center and The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX, USA., Shlien A; Department of Laboratory Medicine and Pathobiology/Department of Paediatric Laboratory Medicine/Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada., Hayashi M; Department of Pediatrics, University of Colorado Anschutz Medical Campus and Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO, USA., Bishop AJR; Greehey Children's Cancer Research Institute and Department of Cell Systems and Anatomy, University of Texas Health at San Antonio, San Antonio, TX, USA., Crompton BD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Shukla N; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Leavey PJ; Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX, USA., Lessnick SL; Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute at Nationwide Children's Hospital, and the Division of Pediatric Heme/Onc/BMT, The Ohio State University College of Medicine, Columbus, OH, USA., Kovar H; St. Anna Children´s Cancer Research Institute (CCRI) and Department Pediatrics Medical University of Vienna, Vienna, Austria., Delattre O; INSERM U830, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, SIREDO Oncology Center, Institut Curie Research Center, Paris, France., Grünewald TGP; Hopp-Children's Cancer Center (KiTZ), Heidelberg/Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK)/Institut of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Antonescu CR; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Roberts RD; Center for Childhood Cancer and Blood Disease, Nationwide Children's Hospital and The Ohio State University, Columbus, OH, USA., Toretsky JA; Departments of Oncology and Pediatrics, Georgetown University, Washington, DC, USA., Tirode F; Univ Lyon, Universite Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Cancer Research Center of Lyon, Centre Leon Berard, F-69008, Lyon, France., Gorlick R; Division of Pediatrics, MD Anderson Cancer Center, Houston, TX, USA., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Reed D; Department of Individualized Cancer Management, Moffitt Cancer Center, Tampa, FL, USA., Lawlor ER; Seattle Children's Research Institute, University of Washington Medical School, Seattle, WA, USA., Grohar PJ; Center for Childhood Cancer Research, Children's Hospital of Philadelphia, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA. GROHARP@EMAIL.CHOP.EDU.
Publikováno v:
NPJ precision oncology [NPJ Precis Oncol] 2022 Sep 17; Vol. 6 (1), pp. 65. Date of Electronic Publication: 2022 Sep 17.
Autor:
Abbou S; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Gustave Roussy Cancer Campus, Department of Pediatric and Adolescent Oncology, INSERM U1015, Université Paris-Saclay, Villejuif, France.; Broad Institute of Harvard and MIT, Cambridge, MA, USA., Finstuen-Magro S; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., McDannell B; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Feenstra M; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Ward A; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Shulman DS; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Geoerger B; Gustave Roussy Cancer Campus, Department of Pediatric and Adolescent Oncology, INSERM U1015, Université Paris-Saclay, Villejuif, France., Duplan J; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Comeau H; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Klega K; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Crompton BD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Briand_crompton@dfci.harvard.edu.; Broad Institute of Harvard and MIT, Cambridge, MA, USA. Briand_crompton@dfci.harvard.edu.
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2022 Aug; Vol. 35 (8), pp. 1022-1033. Date of Electronic Publication: 2022 Mar 28.